to experience the full functionality of mail.com.
Enhanced by Google
July 30, 2015
Amgen hikes 2015 forecast after 2Q increase in profit, sales
Amgen Inc. shares jumped in extended trading after the maker of osteoporosis drug Prolia easily beat Wall Street's ...
July 24, 2015
FDA OK's Odomzo from Novartis for common skin cancer type
A new drug for advanced basal cell carcinoma, an increasingly common cancer in the skin's top layer, has won Food and Drug ...
April 15, 2015
FDA approves new type of heart failure drug from Amgen
Patients with chronic heart failure, a disabling, deadly disease that worsens as the heart gradually pumps less efficiently, ...
March 25, 2015
Science, patients driving rare disease drug research surge
The global pharmaceutical industry is pouring billions of dollars into developing treatments for rare diseases, which once ...
March 02, 2015
GSK completes transaction with Novartis
Britain's GlaxoSmithKline PLC and Switzerland's Novartis AG have completed a three-part deal that will offer the British ...